Best Pharmaceutical Laboratories In San Diego Near Me

4worldlovers: PharmLabs provides the Cannabis community and beyond with laboratory testing and analytic services to ensure access to safe cannabis products.

If your goal is to grow CBD and/or THC rich medical cannabis or achieve a specific THC:CBD ratio, we can help with Potency Testing.

4worldlovers: At Intercept, our focus is to develop and deliver novel medicines for those living with rare and serious liver diseases.

Using key discoveries in the field of liver health, we’re advancing treatments for rare and serious liver diseases. Our portfolio is based on novel scientific targets with the potential for therapeutic application across multiple liver diseases.

Continuing to deliver the only FDA-approved second-line treatment for people living with primary biliary cholangitis (PBC)

Primary biliary cholangitis (PBC) is a rare, progressive, and chronic autoimmune disease that causes bile acid to build up in the liver, resulting in inflammation and scarring (fibrosis), which, if left untreated, can lead to cirrhosis, the need for a liver transplant, or death. Therefore, we believe treatment goals should aim to prevent end-stage liver disease and in turn increase transplant-free survival.

Our whole world was turned upside down when I was diagnosed. The doctor started me on medication, and I know how important it is to get my liver function tested every few months.”

We’ve gathered community resources for education, connection and support for people living with liver diseases, caregivers, family members and those interested in learning more.

Since 2002, we’ve pioneered a novel scientific platform to answer critical needs in the liver health community and deliver on our mission to build a healthier tomorrow for people with rare and serious liver diseases.

We’re a dynamic, fast-paced biopharmaceutical company driven by purposeful curiosity and a willingness to do things that haven’t been done before. We recognize that developing new treatments is challenging and that it takes commitment, dedication and deep scientific knowledge, but we are inspired by the opportunity to have a meaningful impact on the lives of patients. As a team, we deliver on our commitment through true collaboration and partnership.


Our company started as a vision in our founder’s small New York City apartment, and we’ve kept that entrepreneurial spirit as we’ve grown to a commercial-stage company more than 300 people strong with a pipeline of innovative and investigational therapies in development.

Our employees are collaborative, passionate and innovative. We embrace our responsibility of pioneering solutions and building hope for patients in need. If you are someone who is self-motivated and sees challenges as opportunities, join us and help us make a difference for those with rare and serious liver diseases.

4worldlovers: Overreliance on opioids in the postsurgical setting has set off a cascade of negative consequences, ranging from potentially severe adverse events to the risk of long-term use, misuse, and addiction.

4worldlovers:

Catalent is the #1 CDMO partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people's lives.


Catalent Expands OneBio Suite for Integrated Development, Manufacturing and Supply Across Biologic Modalities


To learn more about progress against our corporate responsibility and sustainability strategy, please review our Fiscal 2022 Corporate Responsibility Report.


Explore our facilities through new 360° Virtual Site Tours and Site Tour Videos to get a window into our integrated services, superior drug delivery technologies and manufacturing solutions across the globe.


A comprehensive toolkit that offers a developability assessment specific to protein degraders to help identify orally bioavailable candidates and leverage an array of specialized capabilities to select the right formulation to efficiently get to clinic and beyond.

4worldlovers: Our mission is to develop treatments for patients and parents affected by severe allergic reactions that are safe and effective, needle-free, easy to carry, simple to administer and help eliminate the anxiety and hesitation associated with using an injectable device.

ARS is currently developing a needle-free nasal spray designed to consistently deliver a pharmacodynamic exposure of epinephrine that is similar to existing treatments. Our nasal spray may help reduce hesitation and allow patients to confidently administer when needed.

Patient and Caregiver preparedness to act quickly and confidently during a severe allergic reaction is imperative. Hesitation can lead to worse clinical outcomes and can be fatal. ARS is committed to transforming the way we think about and use life-saving epinephrine.